Skin cancer vaccine BLA submitted by...? — March 31, 2027
79% chance
- Resolves
- Mar 31, 2027
- Volume
- $25.9K
- 24h
- $67
- Liquidity
- $2.7K
Listed on 1 venueChance over time
Yes price, by venuePolymarket USCFTC-regulatedDeposit $10, get $25
Trading bonus for new sign-ups.
Sponsored · We may earn a commission · 18+ · Trade responsibly · 1-800-GAMBLER
Signals
Quiet market: no big moves or venue gaps in the last 24 hours.
Every venue’s price
1 venueEach share pays $1 if it’s right. Green marks the cheapest venue after fees; every price opens that venue’s market.
Before you trade
How each venue settles it
Polymarket (global)
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by March 31, 2027, 11:59 PM ET. Otherwise, this market will resolve to "No". Intismeran autogene refers to the individualized neoantigen therapy developed by Mo…
Full rules on Polymarket (global) ↗About this market
- Category
- Culture
- Resolves
- Wed, March 31, 2027
Compared across 1 venueIn the news
Discussion
Sign in to join the discussion
Sign In